The Relationship Between Metabolic Syndrome and Breast Cancer in Women Referred to Radiotherapy and Chemotherapy Clinics of Tohid Hospital in Sanandaj

Metabolic syndrome or insulin resistance syndrome is described as abdominal obesity, dyslipidemia, fasting blood sugar, and high blood pressure. This study aimed to investigate the relationship between metabolic syndrome and breast cancer.

This case-control study was performed on 222 women with cancer and non-cancer (breast cancer) (111 participants in each group) referred to Tohid and Besat Hospital in Sanandaj in 2014.

The results showed that the prevalence of metabolic syndrome in people with and without breast cancer was 85 (76.6%) and 60 (54.1%), respectively, which was statistically significant.

The results showed that the criteria for defining metabolic syndrome increase cancer risk, especially breast cancer in women, and measures should be taken to reduce these risks in high-risk groups.